Thermo Fisher Scientific TMO Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Thermo Fisher Scientific’s 8-K, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation?
- Thermo Fisher Scientific (TMO) reported cash provided by (used in) financing activity, including discontinued operation of -$1.57B in Q2 2026.
- How has Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation decreased by 58.5% year-over-year, from -$991M to -$1.57B.
- What is the long-term trend for Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation?
- Over 2 years (2021 to 2025), Thermo Fisher Scientific's cash provided by (used in) financing activity, including discontinued operation has grown at a -47.7% compound annual growth rate (CAGR), from $6.58B to $1.8B.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.